The FCR‐1: Initial validation of a single‐item measure of fear of cancer recurrence
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
Objective: Fear of cancer recurrence (FCR) is characterized by the fear, worry or concern that cancer will come back or progress. The negative effects associated with FCR are consistently identified by cancer survivors as one of their most prominent unmet needs. Current measures of FCR can be long, complex and burdensome for survivors to complete. The objective of the present study is to develop and validate a one‐item measure of FCR. Methods: The ability of the FCR‐1 to detect change in FCR over time was analyzed using a repeated‐measures ANOVA and paired‐samples t‐tests. Pearson correlations were used to measure the concurrent, convergent and discriminant validity of the FCR‐1, and a ROC analysis was conducted to determine an optimal clinical cut‐off score. Results: The FCR‐1 was found to be responsive to change in FCR over time. It demonstrated concurrent validity with the FCRI (r = .395, P = .010), and convergent validity with the Mishel Uncertainty in Illness Scale (r = .493, P = .001) and the Reassurance Questionnaire (r = .325, P = .044). Discriminant validity was confirmed when the FCR‐1 did not significantly correlate with unrelated measures. A ROC analysis pinpointed an optimal clinical cut‐off score of 45.0. Conclusions: The FCR‐1 is a promising tool that can be incorporated in clinical and research settings. Due to its brevity, the care needs of highly distressed patients can be met quickly and efficiently. In research settings, the FCR‐1 can reduce the cognitive burden experienced by survivors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fear of cancer recurrence in adult cancer survivors: a systematic review of quantitative studies
Simard, S., Thewes, B., Humphris, G., Dixon, M., Hayden, C., Mireskandari, S., & Ozakinci, G. (2013) · Journal of Cancer Survivorship · doi:10.1007/s11764-013-0272-z · Cited by 1,217 · cited 1×
“Several studies examining gender as a predictor of FCR have found that women report higher rates of FCR than men.(4) High FCR also tends to affect already vulnerable members of the female population, such as socially isolated women and women with lower educational attainment.”
BackgroundSimard, S., & Savard, J. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0444-y · Cited by 608 · cited 1×
“89).(25) Using the present sample, internal consistency was strong (α = .”
BackgroundArmes, J., Crowe, M., Colbourne, L., Morgan, H., Murrells, T., Oakley, C., Palmer, N., Ream, E., Young, A., & Richardson, A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.5151 · Cited by 587
Lebel, S., Ozakinci, G., Humphris, G., Mutsaers, B., Thewes, B., Prins, J., Dinkel, A., Butow, P., & on behalf of the University of Ottawa Fear of Cancer Recurrence Colloquium attendees (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3272-5 · Cited by 586
Self-citationKoch, L., Jansen, L., Brenner, H., & Arndt, V. (2013) · Psycho-Oncology · doi:10.1002/pon.3022 · Cited by 511
Screening and comorbidity of clinical levels of fear of cancer recurrence
Simard, S., & Savard, J. (2015) · Journal of Cancer Survivorship · doi:10.1007/s11764-015-0424-4 · Cited by 329 · cited 1×
“Two potential cut-off scores on the FCRI—13 and 22—have been suggested in the literature.(7,28) While an FCRI cut-off of score 13 was used as eligibility criteria for entry into the study for purposes of sensitivity, our ROC analysis used the FCRI-severity cut-off score of 22 to increase specificity.”
MethodFear of cancer recurrence: a systematic literature review of self‐report measures
Thewes, B., Butow, P., Zachariae, R., Christensen, S., Simard, S., & Gotay, C. (2012) · Psycho-Oncology · doi:10.1002/pon.2070 · Cited by 262
Koch, L., Bertram, H., Eberle, A., Holleczek, B., Schmid-Höpfner, S., Waldmann, A., Zeissig, S. R., Brenner, H., & Arndt, V. (2014) · Psycho-Oncology · doi:10.1002/pon.3452 · Cited by 253
Primary Health and Supportive Care Needs of Long-Term Cancer Survivors: A Questionnaire Survey
Harrison, S. E., Watson, E. K., Ward, A. M., Khan, N. F., Turner, D., Adams, E., Forman, D., Roche, M. F., & Rose, P. W. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.5167 · Cited by 176
Savard, J., & Ivers, H. (2013) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2012.12.013 · Cited by 131 · cited 1×
“Greater FCR is also found to be related to poorer prognosis and health outcomes, such as diagnosis of head and neck cancer, more advanced cancer, and cancer recurrence.(11) Several studies examining gender as a predictor of FCR have found that women report higher rates of FCR than men.”
Background
Research works printed but not linked: 17
- 10.1007/s11764-018-0714-8 · DOI
- Lucas J. M.. Factors Associated with Fear of Breast Cancer Recurrence Among Survivors. [Unpublished doctoral dissertation]. Florida: University of South Florida;2013.
- 10.1054/bjoc.2001.1785 · DOI
- 10.1002/cncr.31133 · DOI
- 10.1002/pon.1128 · DOI
- 10.1016/j.jval.2011.06.003 · DOI · Paper page
- 10.1016/j.jsat.2011.04.005 · DOI · Paper page
- 10.1007/s00520-015-2943-y · DOI
- 10.1097/SPC.0000000000000323 · DOI
- 10.1186/s12885-016-2326-x · DOI · Paper page
- 10.1097/00006842-197905000-00004 · DOI · Paper page
- 10.1192/bjp.180.3.205 · DOI · Paper page
- 10.1002/pon.4516 · DOI · Paper page
- 10.1111/j.1547-5069.1990.tb00225.x · DOI · Paper page
- 10.1017/S0033291799002378 · DOI · Paper page
- 10.1007/s11764-014-0383-1 · DOI
- 10.1007/s00405-015-3585-x · DOI
Cited by
Management of common clinical problems experienced by survivors of cancer
Emery, J., Butow, P., Lai-Kwon, J., Nekhlyudov, L., Rynderman, M., & Jefford, M. (2022) · The Lancet · doi:10.1016/s0140-6736(22)00242-2 · Cited by 326
Spotlight on the Fear of Cancer Recurrence Inventory (FCRI)
Smith, A. B., Costa, D., Galica, J., Lebel, S., Tauber, N., van Helmondt, S. J., & Zachariae, R. (2020) · Psychology Research and Behavior Management · doi:10.2147/prbm.s231577 · Cited by 98
Self-citationFear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?
Bergerot, C. D., Philip, E. J., Bergerot, P. G., Siddiq, N., Tinianov, S., & Lustberg, M. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_100031 · Cited by 90
Emotion-focused therapy for fear of cancer recurrence: A hospital-based exploratory outcome study.
Almeida, S. N., Elliott, R., Silva, E. R., & Sales, C. M. D. (2022) · Psychotherapy · doi:10.1037/pst0000389 · Cited by 12
Metadata
- Authors
- Rudy, L., Maheu, C., Körner, A., Lebel, S., & Gélinas, C.
- Venue
- Psycho-Oncology
- Publisher
- Wiley
- Published
- 2020-02-16
- Volume
- 29
- Issue
- 4
- Pages
- 788-795
- ISSN
- 1057-9249 (ISSN-L)
- 1099-1611
- OpenAlex
- W3005314078
- Cited by
- 40
- References
- 14
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- Canadian Centre for Applied Research in Cancer Control (#2015‐703549)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The FCR‐1: Initial validation of a single‐item measure of fear of cancer recurrence. https://app.cochat.ai/papers/10.1002/pon.5350
- The paper
- Rudy, L., Maheu, C., Körner, A., Lebel, S., & Gélinas, C. (2020). The FCR‐1: Initial validation of a single‐item measure of fear of cancer recurrence. Psycho-Oncology. https://doi.org/10.1002/pon.5350
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.